MYCN and neuroblastoma: This was addressed in silico through comparison of our MCF7 data with publicly available TBX2 ChIP-seq in N-Myc amplified neuroblastoma, the only other known cancer in which TBX2 ChIP-seq has been performed to date (4,10).